The global Breast Reconstruction Market is estimated to be valued at US$ 567 million in 2023
The global Breast Reconstruction Market is estimated to be valued at US$ 567 million in 2023
The global Breast Reconstruction Market is estimated to be valued at US$ 567 million in 2023 and is expected to exhibit a CAGR of 2.7% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

The global Breast Reconstruction Market is estimated to be valued at US$ 567 million in 2023 and is expected to exhibit a CAGR of 2.7% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.


Market Overview:


Breast reconstruction surgery refers to a set of surgical procedures performed to reconstruct the shape and look of the breast after breast cancer treatment or breast trauma. There are several breast reconstruction options available including implant-based and autologous breast reconstruction using donor sites such as the abdomen, back or buttocks. Breast reconstruction has significant advantages for a woman's body image, self-esteem, and psychosocial well-being after breast surgery. The increasing incidences of breast cancer and growing awareness about breast reconstruction surgery are expected to drive the market growth over the forecast period.


Market key trends:


One of the key trends witnessed in the market is the increasing adoption of autologous breast reconstruction. Autologous breast reconstruction provides a more natural looking and feeling reconstructed breast compared to implants since it uses the patient's own tissue. The two most common donor sites used for autologous breast reconstruction are the lower abdomen (TRAM flap) and back (latissimus dorsi flap). However, autologous reconstruction is a longer and more invasive procedure than implant-based reconstruction. Nevertheless, the adoption is growing due to superior aesthetic outcomes. The other important trend in the breast reconstruction market is the increasing availability of breast reconstruction procedures through plastic surgeons. Previously breast reconstruction surgeries were only performed by specialized breast reconstructive surgeons. However, now plastic surgeons are increasingly trained in performing breast reconstruction procedures which has increased the accessibility globally.

Porter’s Analysis


Threat of new entrants: The breast reconstruction market has high setup and operation costs which acts as a barrier for new players to enter the market.
Bargaining power of buyers: Individual customers have low bargaining power due to inelastic demand for breast reconstruction procedures. However, large hospitals and institutions have moderate bargaining power.


Bargaining power of suppliers: Majority of suppliers for reconstructive implants and tissue products face moderate-high bargaining power due to limited number of players operating in this niche segment.


Threat of new substitutes: There exist no close substitutes for breast reconstruction procedures currently. Some alternatives like implants or autologous tissue flaps are available.


Competitive rivalry: The breast reconstruction market is consolidated in nature with key global players occupying majority market share. Competition is high between established industry participants.


Key Takeaways


The Global Breast Reconstruction Market Demand  is expected to witness high growth, exhibiting CAGR of 2.7% over the forecast period, due to increasing prevalence of breast cancer cases globally. The American Cancer Society has estimated over 279,100 new breast cancer cases occurring in women in the United States in 2023.

Regionally, North America is expected to dominate the breast reconstruction market during the forecast period. This is attributed to advanced healthcare infrastructure, availability of skilled surgeons, and rising incidence of breast cancer in the region. Asia Pacific region is anticipated to exhibit the fastest growth rate over 2023-2030 owing to growing medical tourism in China, India and Thailand for reconstructive procedures.

Key players operating in the breast reconstruction market are Polytech Health & Aesthetics GmbH, Allergan, Mentor Worldwide LLC (Johnson & Johnson), Sientra Inc., GC Aesthetics, RTI Surgical, Inc., Groupe Sebbin SAS, Integra LifeSciences, and Wanhe. These established market participants collectively account for majority share of the global market through their diverse portfolios of reconstructive implants and grafts.

 

Read More - https://www.pressreleasebulletin.com/breast-reconstruction-market-analysis-share-size-demand-forecast/

What's your reaction?

Comments

https://www.timessquarereporter.com/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!

Facebook Conversations